These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

282 related items for PubMed ID: 2541445

  • 1. An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines.
    Anfossi G, Gewirtz AM, Calabretta B.
    Proc Natl Acad Sci U S A; 1989 May; 86(9):3379-83. PubMed ID: 2541445
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of c-myb and c-fes antisense oligodeoxynucleotides on granulocytic differentiation of human myeloid leukemia HL60 cells.
    Ferrari S, Donelli A, Manfredini R, Sarti M, Roncaglia R, Tagliafico E, Rossi E, Torelli G, Torelli U.
    Cell Growth Differ; 1990 Nov; 1(11):543-8. PubMed ID: 2088479
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
    Hoffman-Liebermann B, Liebermann DA.
    Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of leukemia cell proliferation by receptor-mediated uptake of c-myb antisense oligodeoxynucleotides.
    Citro G, Perrotti D, Cucco C, D'Agnano I, Sacchi A, Zupi G, Calabretta B.
    Proc Natl Acad Sci U S A; 1992 Aug 01; 89(15):7031-5. PubMed ID: 1495997
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oligonucleotide N3'-->P5' phosphoramidates as antisense agents.
    Gryaznov S, Skorski T, Cucco C, Nieborowska-Skorska M, Chiu CY, Lloyd D, Chen JK, Koziolkiewicz M, Calabretta B.
    Nucleic Acids Res; 1996 Apr 15; 24(8):1508-14. PubMed ID: 8628685
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship of acivicin-induced monocytoid differentiation of human myeloid leukemia cells to acivicin-induced modulation of growth factor, cytokine, and protooncogene mRNA expression.
    Weinberg JB, Mason SN.
    Cancer Res; 1991 Feb 15; 51(4):1202-9. PubMed ID: 1997162
    [Abstract] [Full Text] [Related]

  • 19. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma.
    Williams SA, Gillan ER, Knoppel E, Buzby JS, Suen Y, Cairo MS.
    Ann Oncol; 1997 Feb 15; 8 Suppl 1():25-30. PubMed ID: 9187425
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.